Outcome of Board Meeting
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Sattva Sukun Lifecare Ltd (formerly Mayukh Dealtrade Ltd) approved unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, along with the Statutory Auditor's Limited Review Report. On a standalone basis, the company swung to a loss in Q3 FY26 with a net profit of Rs (70.66) lakhs versus a profit of Rs 60.40 lakhs in Q2 FY26, and standalone revenue dropped sharply to Rs 72.75 lakhs from Rs 195.54 lakhs in the year-ago quarter. For the nine months ended December 2025, standalone net profit fell to Rs 73.48 lakhs from Rs 164.80 lakhs in the corresponding prior period, a decline of about 55%. Consolidated nine-month revenue rose significantly to Rs 2,374.61 lakhs from Rs 421.14 lakhs, driven by subsidiary contributions, though Q3 consolidated also posted a loss of Rs (69.49) lakhs. The Board also noted that Rs 1,916 lakhs raised via Rights Issue in July 2025 has been utilized with no deviation from stated objects (Rs 1,808 lakhs used by Dec 31, 2025). Various policies including Related Party Transactions, Insider Trading, and Whistle Blower were reviewed and found compliant.
Negative short-term sentiment: standalone business shifted to a quarterly loss with steep YoY revenue decline, though consolidated top-line grew materially due to subsidiaries. Rights Issue funds are on track with no deviation, but investors should watch whether the standalone business stabilizes in the next quarter.